ociation of the Variants CASP 8 D 302 H and CASP 10 0 I with Breast and Ovarian Cancer Risk in B & P A 1 and BRCA 2 Mutation Carriers

oph Engel, Beatrix Versmold, Barbara Wappenschmidt, Jacques Simard, Douglas F. Easton, Susan Peock, ret Cook, Clare Oliver, Debra Frost, Rebecca Mayes, D. Gareth Evans, Rosalind Eeles, Joan Paterson, Brewer ; for the Epidemiological Study of Familial Breast Cancer (EMBRACE), Lesley McGuffog, is C. Antoniou, Dominique Stoppa-Lyonnet, Olga M. Sinilnikova, Laure Barjhoux, Marc Frenay, Michel, Dominique Leroux, Helene Dreyfus, Christine Toulas, Laurence Gladieff, Nancy Uhrhammer, Jean Bignon, Alfons Meindl, Norbert Arnold, Raymonda Varon-Mateeva, Dieter Niederacher, e Preisler-Adams, Karin Kast, Helmut Deissler, Christian Sutter, Dorothea Gadzicki, ia Chenevix-Trench, Amanda B. Spurdle, Xiaoqing Chen, Jonathan Beesley; for the Kathleen gham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Håkan Olsson, istoffersson, Hans Ehrencrona, Annelie Liljegren; for the Swedish Breast Cancer Study, Sweden (SWE-BRCA), . van der Luijt, Theo A. van Os, Flora E. van Leeuwen; for the Hereditary Breast and Ovarian cancer Netherlands (HEBON), Susan M. Domchek, Timothy R. Rebbeck, Katherine L. Nathanson, Ana Osorio, a Ramón y Cajal, Irene Konstantopoulou, Javier Benítez, Eitan Friedman, Bella Kaufman, Yael Laitman, g L. Mai, Mark H. Greene, Heli Nevanlinna, Kristiina Aittomäki, Csilla I. Szabo, Trinidad Caldes, s J. Couch, Irene L. Andrulis, Andrew K. Godwin, Ute Hamann, and Rita K. Schmutzler; half of the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

[1]  A. Howell,et al.  Breast cancer susceptibility variants alter risk in familial ovarian cancer , 2010, Familial Cancer.

[2]  M. Beckmann,et al.  Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium , 2009, Cancer Epidemiology Biomarkers & Prevention.

[3]  N. Camp,et al.  A breast cancer risk haplotype in the caspase-8 gene. , 2009, Cancer research.

[4]  J. Chang-Claude,et al.  Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[5]  Maurizio Sabatti,et al.  Allele-specific PCR in SNP genotyping. , 2009, Methods in molecular biology.

[6]  A. Whittemore,et al.  Consortium analysis of 7 candidate SNPs for ovarian cancer , 2008, International journal of cancer.

[7]  A. Cox,et al.  The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study , 2008, Breast Cancer Research and Treatment.

[8]  N. Rothman,et al.  Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults , 2007, Cancer Epidemiology Biomarkers & Prevention.

[9]  Changqing Zeng,et al.  A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers , 2007, Nature Genetics.

[10]  Georgia Chenevix-Trench,et al.  An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.

[11]  N. Rothman,et al.  Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. , 2006, Carcinogenesis.

[12]  R. Siegel.  Caspases at the crossroads of immune-cell life and death , 2006, Nature Reviews Immunology.

[13]  J. Chang-Claude,et al.  A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.

[14]  O. Cuvillier,et al.  Caspase-10 Triggers Bid Cleavage and Caspase Cascade Activation in FasL-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[15]  B. Zhivotovsky,et al.  Polymorphic variations in apoptotic genes and cancer predisposition , 2005, Cell Death and Differentiation.

[16]  W. Park,et al.  Inactivating mutations of caspase-8 gene in colorectal carcinomas. , 2003, Gastroenterology.

[17]  M. Shin,et al.  Inactivating mutations of the caspase-10 gene in gastric cancer , 2002, Oncogene.

[18]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[19]  L. J. Wei,et al.  The Robust Inference for the Cox Proportional Hazards Model , 1989 .